Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial
RNA 特征对接受 12 周新辅助帕妥珠单抗联合曲妥珠单抗（含或不含紫杉醇）治疗后 pCR 和生存率的影响（WSG-ADAPT HER2+/HR- 试验）
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-1587
Graeser, Monika; Gluz, Oleg; Biehl, Claudia; Ulbrich-Gebauer, Daniel; Christgen, Matthias; Palatty, Jenci; Kuemmel, Sherko; Grischke, Eva-Maria; Augustin, Doris; Braun, Michael; Potenberg, Jochem; Wuerstlein, Rachel; Krauss, Katja; Schumacher, Claudia; Forstbauer, Helmut; Reimer, Toralf; Stefek, Andrea; Fischer, Hans Holger; Pelz, Enrico; Zu Eulenburg, Christine; Kates, Ronald; Ni, Hua; Kolberg-Liedtke, Cornelia; Feuerhake, Friedrich; Kreipe, Hans Heinrich; Nitz, Ulrike; Harbeck, Nadia
